So Yeon Kim, Dong-Yeop Shin, Seung-Sook Lee, Cheolwon Suh, Jae-Yong Kwak, Hoon-Gu Kim, Jae Hoon Lee, Soon Il Lee, Ye Rim Lee, Seung Hwa Kang, Se Kwon Mun, Min Jae Lee, Hyo-Rak Lee, Sung Hyun Yang, and Hye Jin Kang
Korean J Hematol 2012; 47(3): 213-218Hee Won Moon, Tae Young Kim, Bo Ra Oh, Sang Mee Hwang, Jiseok Kwon, Ja-Lok Ku, and Dong Soon Lee
Korean J Hematol 2012; 47(3): 219-224Ji Hun Jeong, Jeong Yeal Ahn, Soon Ho Park, Mi Jung Park, Kyung Hee Kim, and Jun Shik Hong
Korean J Hematol 2012; 47(3): 225-228Anshu Palta, Pratibha Dhiman, and Sanjay D. Cruz
Korean J Hematol 2012; 47(3): 229-232Hea-Lin Oh, Hae-Ryong Kang, Seok-Cheol Jeon, and Young-Ho Lee
Korean J Hematol 2012; 47(3): 233-236Tae-Dong Jeong, M.D., Seongsoo Jang, M.D. Ph.D., Chan-Jeoung Park, M.D. Ph.D., and Hyun-Sook Chi, M.D. Ph.D.
Korean J Hematol 2012; 47(3): 237-238
Overall survival according to pericardial involvement in the malignant disease. The pericardial involvement group had a significantly poorer survival rate than the non-pericardial involvement group (